Baton Rouge-based biopharmaceutical manufacturer TransGenRx has entered into a seven-year agreement with Novocyt to produce growth factor proteins intended for use in new human biopharmaceuticals. The…
Already an INSIDER? Sign in.
Deal could give boost to B.R. pharmaceutical research
